M
Michael I. Bennett
Researcher at University of Leeds
Publications - 290
Citations - 17312
Michael I. Bennett is an academic researcher from University of Leeds. The author has contributed to research in topics: Palliative care & Cancer pain. The author has an hindex of 52, co-authored 266 publications receiving 13680 citations. Previous affiliations of Michael I. Bennett include United Nations Industrial Development Organization & Lancaster University.
Papers
More filters
Journal ArticleDOI
Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendations.
Oliver van Hecke,Peter R. Kamerman,Nadine Attal,Ralf Baron,Gyda Bjornsdottir,David L.H. Bennett,Michael I. Bennett,Didier Bouhassira,Luda Diatchenko,Roy Freeman,Rainer Freynhagen,Maija Haanpää,Troels S. Jensen,Srinivasa N. Raja,Andrew S.C. Rice,Zeʼev Seltzer,Thorgeir E. Thorgeirsson,David Yarnitsky,Blair H. Smith +18 more
TL;DR: This study aimed to provide guidelines on collecting and reporting phenotypes in cases and controls for genetic studies, and identified a basic “entry level” set of phenotypes that can be expanded by more extensive and specific measures, as determined by scientific requirements and resource availability.
Journal ArticleDOI
Oxycodone for cancer-related pain.
TL;DR: The quality of this evidence base was limited by the risk of bias of the studies and by small sample sizes for many outcomes, but the finding that none of the included studies reported differences in pain intensity between the treatment groups was significant.
Journal ArticleDOI
Oxycodone for cancer-related pain.
TL;DR: Whether oxycodone is associated with better pain relief and tolerability than other analgesic options for adults with cancer pain is assessed by examining pain intensity/relief, adverse events, quality of life, and participant preference.
Journal ArticleDOI
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives.
TL;DR: The challenges surrounding the use of opioids, and the need for safe and effective alternative analgesics, are leading to intense interest in the potential benefits of cannabis for cancer-related pain.
Journal ArticleDOI
Opioids combined with antidepressants or antiepileptic drugs for cancer pain: Systematic review and meta-analysis.
TL;DR: Combining opioid analgesia with gabapentinoids did not significantly improve pain relief in patients with tumour-related cancer pain compared with opioid monotherapy, and Clinicians should balance the small likelihood of benefit in Patients with tumours- related cancer pain against the increased risk of adverse effects of combination therapy.